Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Olanzapine-Induced Weight Gain in Healthy Men
NCT00455442Phase 2Completed
- Sponsor
- Corcept Therapeutics
- Start
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone, sponsored by Corcept Therapeutics. Started Mar 2007; status: completed.
02
Drugs
mifepristone
Beyond the preview
Go deeper on NCT00455442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455442.